Form 4 for CVKD Cadrenal Therapeutics, Inc.
Accepted 2023-10-06 00:00:00 ET · period of report 2023-10-04 · accession 0001213900-23-081216 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-10-06 | 2023-10-04+ | CVKD | MURPHY JOHN RAYMOND | Dir | P - Purchase | $0.6987 | +20.0K | 614.8K | +3% | +$14.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-04 | P | A | 17,331 | $0.7 | 612,123 | D | — | — | |
| 2 | Common | Common Stock | 2023-10-05 | P | A | 2,669 | $0.69 | 614,792 | D | — | — |